Updated epithelial barrier dysfunction in chronic rhinosinusitis: Targeting pathophysiology and treatment response of tight junctions

Allergy. 2024 May;79(5):1146-1165. doi: 10.1111/all.16064. Epub 2024 Feb 19.

Abstract

Tight junction (TJ) proteins establish a physical barrier between epithelial cells, playing a crucial role in maintaining tissue homeostasis by safeguarding host tissues against pathogens, allergens, antigens, irritants, etc. Recently, an increasing number of studies have demonstrated that abnormal expression of TJs plays an essential role in the development and progression of inflammatory airway diseases, including chronic obstructive pulmonary disease, asthma, allergic rhinitis, and chronic rhinosinusitis (CRS) with or without nasal polyps. Among them, CRS with nasal polyps is a prevalent chronic inflammatory disease that affects the nasal cavity and paranasal sinuses, leading to a poor prognosis and significantly impacting patients' quality of life. Its pathogenesis primarily involves dysfunction of the nasal epithelial barrier, impaired mucociliary clearance, disordered immune response, and excessive tissue remodeling. Numerous studies have elucidated the pivotal role of TJs in both the pathogenesis and response to traditional therapies in CRS. We therefore to review and discuss potential factors contributing to impair and repair of TJs in the nasal epithelium based on their structure, function, and formation process.

Keywords: chronic rhinosinusitis; epithelial barrier theory; nasal epithelial cells; nasal polyps; tight junctions.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chronic Disease
  • Disease Susceptibility
  • Humans
  • Nasal Mucosa* / immunology
  • Nasal Mucosa* / metabolism
  • Rhinitis* / etiology
  • Rhinitis* / therapy
  • Rhinosinusitis
  • Sinusitis* / etiology
  • Sinusitis* / immunology
  • Sinusitis* / therapy
  • Tight Junctions* / metabolism